Our focus on the life sciences
We are an international life sciences investor. Our portfolio includes private and publicly held companies at all stages of development from start-ups to mature enterprises. We leverage our healthcare heritage to provide capital, know-how, and a valuable network to our portfolio companies.
Healthcare
Our teams invest across various healthcare subsectors. We focus on innovative companies developing new or improved medical therapies, or solutions to increase quality, improve efficiency or lower costs in healthcare.
Life Science Key Figures
€4.6bn
Deployed into life sciences in 2024
300+
Life science investments since 1999
43
New companies added to our Investment Portfolio in 2024
News
01/30/2026
Novo Holdings Closes Sale of KabaFusion
Read more
News
01/20/2026
Novo Holdings Invests in Surya Hospitals to Strengthen Access to High-Quality Women’s and Children’s Healthcare in India
Read more
Reports
01/12/2026
Novo Holdings publishes its 2025 Venture Investments Annual Review and Business Update
Read more
Reports
01/9/2026
Novo Holdings publishes its 2025 Seed Investments Annual Review and Business Update
Read more